Anna Wurtz

3PUBLICATIONS
54CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 06, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.

Ioannis P Trontzas, Mengni He, Anna Wurtz

|Feb 15, 2024
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.

Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel

|Mar 13, 2023
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.

Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett

Pageof 1